Published in Neurology on July 01, 1977
Glycerol adjuvant therapy in adults with bacterial meningitis in a high HIV seroprevalence setting in Malawi: a double-blind, randomised controlled trial. Lancet Infect Dis (2011) 2.32
Agreement of measured and calculated serum osmolality during the infusion of mannitol or hypertonic saline in patients after craniotomy: a prospective, double-blinded, randomised controlled trial. BMC Anesthesiol (2015) 0.80
Meta-analysis of studies comparing adjuvant dexamethasone to glycerol to improve clinical outcome of bacterial meningitis. J Res Med Sci (2016) 0.75
Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients. Brain (2000) 7.95
Neurological complications of acquired immune deficiency syndrome: analysis of 50 patients. Ann Neurol (1983) 5.98
Magnetic resonance image tissue classification using a partial volume model. Neuroimage (2001) 5.87
Diagnosis and treatment of leptomeningeal metastases from solid tumors: experience with 90 patients. Cancer (1982) 4.40
A serologic marker of paraneoplastic limbic and brain-stem encephalitis in patients with testicular cancer. N Engl J Med (1999) 3.58
HuD, a paraneoplastic encephalomyelitis antigen, contains RNA-binding domains and is homologous to Elav and Sex-lethal. Cell (1991) 3.33
Uronic acid constituents of oat-coleoptile cell walls. Biochem J (1964) 3.24
Anti-Hu--associated paraneoplastic encephalomyelitis/sensory neuronopathy. A clinical study of 71 patients. Medicine (Baltimore) (1992) 3.21
Paraneoplastic cerebellar degeneration. I. A clinical analysis of 55 anti-Yo antibody-positive patients. Neurology (1992) 3.11
Distribution of brain metastases. Arch Neurol (1988) 3.11
Epidural spinal cord compression from metastatic tumor: diagnosis and treatment. Ann Neurol (1978) 3.08
Nova, the paraneoplastic Ri antigen, is homologous to an RNA-binding protein and is specifically expressed in the developing motor system. Neuron (1993) 2.81
Radiation-induced dementia in patients cured of brain metastases. Neurology (1989) 2.59
Detection of the anti-Hu antibody in the serum of patients with small cell lung cancer--a quantitative western blot analysis. Ann Neurol (1990) 2.58
Selective expression of Purkinje-cell antigens in tumor tissue from patients with paraneoplastic cerebellar degeneration. N Engl J Med (1990) 2.54
Cerebrovascular complications in patients with cancer. Medicine (Baltimore) (1985) 2.39
Ma1, a novel neuron- and testis-specific protein, is recognized by the serum of patients with paraneoplastic neurological disorders. Brain (1999) 2.35
Infiltration of the leptomeninges by systemic cancer. A clinical and pathologic study. Arch Neurol (1974) 2.33
Effect of brain irradiation on demyelinating lesions. Neurology (1993) 2.21
Anti-Hu antibodies in patients with small-cell lung cancer: association with complete response to therapy and improved survival. J Clin Oncol (1997) 2.19
Long-term clinical outcome of paraneoplastic cerebellar degeneration and anti-Yo antibodies. Neurology (2000) 2.17
Molecular and clinical diversity in paraneoplastic immunity to Ma proteins. Ann Neurol (2001) 2.15
Malignant cells in cerebrospinal fluid (CSF): the meaning of a positive CSF cytology. Neurology (1979) 2.13
Sumatriptan-induced stroke in sagittal sinus thrombosis. Lancet (1994) 2.05
Cloning of a brain protein identified by autoantibodies from a patient with paraneoplastic cerebellar degeneration. Proc Natl Acad Sci U S A (1987) 2.05
Spinal-fluid pH and neurologic symptoms in systemic acidosis. N Engl J Med (1967) 1.93
Intracranial metastases from systemic cancer. Adv Neurol (1978) 1.92
The expression of the Hu (paraneoplastic encephalomyelitis/sensory neuronopathy) antigen in human normal and tumor tissues. Am J Pathol (1992) 1.91
Qualitative and quantitative evaluation of six algorithms for correcting intensity nonuniformity effects. Neuroimage (2001) 1.90
Neuronal antinuclear antibody in sensory neuronopathy from lung cancer. Neurology (1985) 1.86
Motor neuron syndromes in cancer patients. Ann Neurol (1997) 1.82
MRI changes in intracranial hypotension. Neurology (1993) 1.80
Jugular bulb saturation and cognitive dysfunction after cardiopulmonary bypass. Ann Thorac Surg (1994) 1.80
Sensory neuronopathy and small cell lung cancer. Antineuronal antibody that also reacts with the tumor. Am J Med (1986) 1.79
Subacute encephalitis in acquired immune deficiency syndrome: a postmortem study. Am J Clin Pathol (1984) 1.79
Pituitary metastasis: incidence in cancer patients and clinical differentiation from pituitary adenoma. Neurology (1981) 1.78
Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome. Brain (1997) 1.73
Brachial plexus lesions in patients with cancer: 100 cases. Neurology (1981) 1.70
Radiation therapy for brain metastases. Ann Neurol (1980) 1.68
Epidural spinal cord compression from metastatic tumor: results with a new treatment protocol. Ann Neurol (1980) 1.68
Autoantibodies in paraneoplastic syndromes associated with small-cell lung cancer. Neurology (1988) 1.66
Cerebral metabolic and circulatory responses to induced convulsions in animals. Arch Neurol (1968) 1.66
Autoantibody synthesis in the central nervous system of patients with paraneoplastic syndromes. Neurology (1990) 1.65
Paraneoplastic cerebellar degeneration: clinical-immunological correlations. Ann Neurol (1988) 1.63
Metastasis to the base of the skull: clinical findings in 43 patients. Neurology (1981) 1.61
Perforation of the gastrointestinal tract in patients receiving steroids for neurologic disease. Neurology (1988) 1.59
Subacute sensory neuropathy: a remote effect of carcinoma. Ann Neurol (1977) 1.58
Steroid myopathy in cancer patients. Neurology (1997) 1.57
Ataxia in epidural spinal cord compression. Neurology (1992) 1.55
Neurologic complications of carcinoid. Neurology (1986) 1.54
Scaled subprofile model: a statistical approach to the analysis of functional patterns in positron emission tomographic data. J Cereb Blood Flow Metab (1987) 1.53
Autoimmune response of patients with paraneoplastic cerebellar degeneration to a Purkinje cell cytoplasmic protein antigen. Ann Neurol (1985) 1.46
Degeneration of the central nervous system associated with celiac disease. J Neurol Sci (1982) 1.44
Subacute motor neuronopathy: a remote effect of lymphoma. Ann Neurol (1979) 1.42
Differences in cerebral blood flow and glucose utilization in vegetative versus locked-in patients. Ann Neurol (1987) 1.42
Paraneoplastic cerebellar degeneration. III. Cerebellar degeneration, cancer, and the Lambert-Eaton myasthenic syndrome. Neurology (1992) 1.41
Cloning of a leucine-zipper protein recognized by the sera of patients with antibody-associated paraneoplastic cerebellar degeneration. Proc Natl Acad Sci U S A (1991) 1.41
The role of postoperative radiotherapy after resection of single brain metastases. Neurosurgery (1989) 1.40
Partial characterization of the Purkinje cell antigens in paraneoplastic cerebellar degeneration. Neurology (1986) 1.39
Hu antigens: reactivity with Hu antibodies, tumor expression, and major immunogenic sites. Ann Neurol (1995) 1.37
Major histocompatibility proteins, anti-Hu antibodies, and paraneoplastic encephalomyelitis in neuroblastoma and small cell lung cancer. Cancer (1995) 1.36
Swallow syncope. Report of a case and review of the literature. Neurology (1972) 1.35
Opsoclonus, myoclonus, ataxia, and encephalopathy in adults with cancer: a distinct paraneoplastic syndrome. Medicine (Baltimore) (1988) 1.35
Central nervous system infections in patients with cancer. Medicine (Baltimore) (1973) 1.34
Detection of sequences homologous to human retroviral DNA in multiple sclerosis by gene amplification. Proc Natl Acad Sci U S A (1989) 1.32
Management of central nervous system metastases. Semin Oncol (1977) 1.32
Neurologic paraneoplastic antibodies (anti-Yo; anti-Hu; anti-Ri): the case for a nomenclature based on antibody and antigen specificity. Neurology (1994) 1.32
The diagnosis of stupor and coma. Contemp Neurol Ser (1972) 1.26
Detection of the anti-Hu antibody in specific regions of the nervous system and tumor from patients with paraneoplastic encephalomyelitis/sensory neuronopathy. Neurology (1991) 1.26
Headaches in patients with brain tumors: a study of 111 patients. Neurology (1993) 1.25
Morbidity and mortality of craniotomy for excision of supratentorial gliomas. Neurology (1988) 1.22
Necrotizing encephalopathy following intraventricular instillation of methotrexate. Arch Neurol (1973) 1.22
Hyponatremia in acute polyneuropathy. Four cases with the syndrome of inappropriate secretion of antidiuretic hormone. Arch Neurol (1967) 1.21
Risk of ischemic heart disease in patients with TIA. Neurology (1984) 1.21
Paraneoplastic cerebellar degeneration. II. Clinical and immunologic findings in 21 patients with Hodgkin's disease. Neurology (1992) 1.21
Brain metastasis from melanoma. J Neurooncol (1983) 1.21
Cerebellar degeneration-related antigen: a highly conserved neuroectodermal marker mapped to chromosomes X in human and mouse. Proc Natl Acad Sci U S A (1990) 1.19
Erythema multiforme and Stevens-Johnson syndrome in patients receiving cranial irradiation and phenytoin. Neurology (1988) 1.19
Immunological and pathological study of anti-Ri-associated encephalopathy. Ann Neurol (1994) 1.19
Human brain tumor transplantation into nude mice. J Natl Cancer Inst (1979) 1.18
T-cell receptor analysis in anti-Hu associated paraneoplastic encephalomyelitis. Neurology (1998) 1.18
Spinal subdural hematomas complicating lumbar puncture. Arch Neurol (1974) 1.17
Inflammatory infiltrates and complete absence of Purkinje cells in anti-Yo-associated paraneoplastic cerebellar degeneration. Acta Neuropathol (1996) 1.16
Treatment of experimental spinal cord compression caused by extradural neoplasms. J Neurosurg (1977) 1.15
Alzheimer's disease: genetic aspects and associated clinical disorders. Ann Neurol (1983) 1.12
Graphical analysis of MR feature space for measurement of CSF, gray-matter, and white-matter volumes. J Comput Assist Tomogr (1993) 1.12
Immunization with the paraneoplastic encephalomyelitis antigen HuD does not cause neurologic disease in mice. Neurology (1995) 1.11
Paraneoplastic neurologic syndromes: pathogenesis and physiopathology. Brain Pathol (1999) 1.10
Intramedullary spinal cord metastases. Clinical and radiographic findings in nine cases. Neurology (1972) 1.10
Incidence and treatment of peripheral venous thrombosis in patients with glioma. Ann Neurol (1983) 1.10
Mutant herpes simplex virus induced regression of tumors growing in immunocompetent rats. J Neurooncol (1994) 1.09
Cerebral infarction from non-bacterial thrombotic endocarditis. Clinical and pathological study including the effects of anticoagulation. Am J Med (1987) 1.09
Experimental spinal cord compression by epidural neoplasm. Neurology (1977) 1.08
Transplantation of human fetal dopamine cells for Parkinson's disease. Results at 1 year. Arch Neurol (1990) 1.07
Nonmetastatic superior sagittal sinus thrombosis complicating systemic cancer. Neurology (1979) 1.07
Central nervous system infections in patients with cancer. Changing patterns. Cancer (1977) 1.06
Herpes simplex encephalitis in an anergic patient. Am J Med (1973) 1.06
Syncope from head and neck cancer. J Neurooncol (1983) 1.05
Paraneoplastic syndromes. Arch Neurol (1999) 1.04
Early-onset Alzheimer's disease: clinical predictors of institutionalization and death. Neurology (1987) 1.04